Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Erchen Tang (also known as Erchen Decoction) is a foundational Traditional Chinese Medicine (TCM) formula first recorded in the 'Tai Ping Hui Min He Ji Ju Fang.' It is traditionally indicated for 'damp-phlegm' syndromes, characterized by cough with abundant white sputum, nausea, and chest congestion. The formula typically comprises four primary herbs: *Pinellia ternata* (Banxia), *Citrus reticulata* (Chenpi), *Poria cocos* (Fuling), and *Glycyrrhiza uralensis* (Gancao). Modern pharmacological research indicates that Erchen Tang exerts anti-inflammatory, immunomodulatory, and metabolic-regulating effects. It has been shown to inhibit the PI3K/AKT/NF-κB signaling pathway, thereby reducing the expression of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Clinically, it is investigated for its efficacy in treating community-acquired pneumonia and hyperlipidemia, often as part of integrated therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on erchen tang.